(NASDAQ: TFFP) Tff Pharmaceuticals's forecast annual revenue growth rate of 136.51% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Tff Pharmaceuticals's revenue in 2024 is $733,871.On average, 1 Wall Street analysts forecast TFFP's revenue for 2024 to be $1,511,532, with the lowest TFFP revenue forecast at $1,511,532, and the highest TFFP revenue forecast at $1,511,532. On average, 1 Wall Street analysts forecast TFFP's revenue for 2025 to be $1,511,532, with the lowest TFFP revenue forecast at $1,511,532, and the highest TFFP revenue forecast at $1,511,532.
In 2026, TFFP is forecast to generate $29,046,607 in revenue, with the lowest revenue forecast at $29,046,607 and the highest revenue forecast at $29,046,607.